TransMedics Group, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TransMedics Group, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $1.01M, a 85.77% decline year-over-year.
- TransMedics Group, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $2.21M, a 26.98% increase year-over-year.
- TransMedics Group, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $1.82M, a 71.80% decline year-over-year.
- TransMedics Group, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $7.09M, a 33.38% decline year-over-year.
- TransMedics Group, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $13.75M, a 33.95% decline from fiscal 2024.
- TransMedics Group, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $20.81M, a 238.15% increase from fiscal 2023.
- TransMedics Group, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $6.16M, a 31.88% increase from fiscal 2022.
- TransMedics Group, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $4.67M, a 379.16% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $1.01M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $2.21M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $13.75M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $1.82M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $7.09M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $1.74M 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $20.81M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $6.44M 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $10.64M 10-Q · filed 2025-10-29 | |
| 2024-03-31 | $2.55M 10-Q · filed 2025-10-29 | |
| 2023-12-31 | $6.16M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $952.00K 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $705.00K 10-Q · filed 2024-10-29 | |
| 2023-03-31 | $3.57M 10-Q · filed 2024-10-29 | |
| 2022-12-31 | $4.67M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $1.44M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $237.00K 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $202.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $974.00K 10-K · filed 2024-02-27 | |
| 2021-09-30 | $344.00K 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $213.00K 10-Q · filed 2022-11-04 | |
| 2021-03-31 | $372.00K 10-Q · filed 2022-11-04 | |
| 2020-12-31 | $227.00K 10-K · filed 2023-02-27 | |
| 2020-09-30 | $27.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $92.00K 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $75.00K 10-Q · filed 2021-11-09 | |
| 2019-12-28 | $202.00K 10-K · filed 2021-03-11 | |
| 2019-09-28 | $94.00K 10-Q · filed 2020-11-06 | |
| 2019-06-29 | $6.00K 10-Q · filed 2020-11-06 | |
| 2019-03-30 | $8.00K 10-Q · filed 2020-11-06 | |
| 2019-03-29 | $8.00K 10-Q · filed 2019-08-08 | |
| 2018-12-29 | $46.00K 10-K · filed 2020-03-17 | |
| 2018-09-29 | $24.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $9.00K 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $12.00K 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |